-
18740-10Inhibitor of Cdk1/cyclin B and Cdk/p25 (IC<sub>50</sub>s = 600 and 400 nM, respectively).
-
18740-5Inhibitor of Cdk1/cyclin B and Cdk/p25 (IC<sub>50</sub>s = 600 and 400 nM, respectively).
-
15154-1A 3-(benzylidne)indolin-2-one analog that selectively and potently inhibits Cdk2 (IC<sub>50</sub> = 60 nM).
-
15154-5A 3-(benzylidne)indolin-2-one analog that selectively and potently inhibits Cdk2 (IC<sub>50</sub> = 60 nM).
-
15154-500A 3-(benzylidne)indolin-2-one analog that selectively and potently inhibits Cdk2 (IC<sub>50</sub> = 60 nM).
-
17648-1A cell-permeable, asymmetrical indolocarbazole that exhibits antiproliferative activity by selectively blocking cyclin D1/Cdk4 (IC<sub>50</sub> = 0.8 &muM) inhibits HCT116 and NCI-H460 tumor cell growth (IC<sub>50</sub>s 1 cell cycle arrest.
-
17648-5A cell-permeable, asymmetrical indolocarbazole that exhibits antiproliferative activity by selectively blocking cyclin D1/Cdk4 (IC<sub>50</sub> = 0.8 &muM) inhibits HCT116 and NCI-H460 tumor cell growth (IC<sub>50</sub>s 1 cell cycle arrest.
-
17648-500A cell-permeable, asymmetrical indolocarbazole that exhibits antiproliferative activity by selectively blocking cyclin D1/Cdk4 (IC<sub>50</sub> = 0.8 &muM) inhibits HCT116 and NCI-H460 tumor cell growth (IC<sub>50</sub>s 1 cell cycle arrest.
-
17974-1A cell-permeable triaminopyrimidine that selectively and reversibly blocks Cdk4/cyclin D1 and Cdk6/cyclin D1 activity (IC<sub>50</sub>s = 1.5 and 5.
-
17974-10A cell-permeable triaminopyrimidine that selectively and reversibly blocks Cdk4/cyclin D1 and Cdk6/cyclin D1 activity (IC<sub>50</sub>s = 1.5 and 5.
-
17974-5A cell-permeable triaminopyrimidine that selectively and reversibly blocks Cdk4/cyclin D1 and Cdk6/cyclin D1 activity (IC<sub>50</sub>s = 1.5 and 5.
-
17477-1A synthetic peptide (PKTPKKAKKL) corresponding to a sequence of histone H1 phosphorylated by Cdk5 with a Km value of 5 µM.